Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/WAVE stock hub

TSXV/WAVE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/WAVEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

540K

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/WAVE

In the news

Latest news · TSXV/WAVE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-22.9

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/WAVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

CAD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 3.7M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA94357L1058
Last refreshed	2026-05-10
Market cap	CAD 540,000
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsxv/WAVE
Website	https://www.waverleypharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-92.45%
EV Earnings	-7.4x
EV/Sales	2.74x
P/B ratio	-0.21x
P/S ratio	0.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-25.88%
EBITDA Margin	-19.71%
Gross margin	38.06%
Gross Profit	CAD 513,677
Gross Profit Growth	139.99%
Gross Profit Growth Q	-40.45%
Gross Profit Growth3 Y	21.87%
Gross Profit Growth5 Y	23.1%
Net Income	CAD -499,214
Pretax Margin	-36.87%
Profit Margin	-36.99%
ROA	-13.27
Roa5y	-25.07
ROCE	14.61
ROIC	-22.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr3y	-41.51%
Cagr5y	-41.01%
Revenue Growth	183.9x
Revenue Growth Q	-34.43x
Revenue Growth3 Y	2.68x
Revenue Growth5 Y	-0.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.82
Assets	CAD 1.2M
Cash	CAD 44,950
Current Assets	CAD 420,825
Current Liabilities	CAD 3.6M
Debt	CAD 3.4M
Equity	CAD -2.6M
Interest Coverage	-1.97
Liabilities	CAD 3.8M
Long Term Assets	CAD 823,513
Long Term Liabilities	CAD 178,884
Net Cash	CAD -3.4M
Net Cash By Market Cap	CAD -630
Tangible Book Value	CAD -3.1M
Tangible Book Value Per Share	CAD -0.06
WACC	5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.12
Inventory Turnover	2.94
Net Working Capital	CAD 5,231
Quick ratio	0.02
Working Capital	CAD -3.2M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	0.02
3Y total return	-80%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.86%
All Time High	0.6
All Time High Change	-98.33%
All Time High Date	2017-10-30
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-08-23
ATR	0
Beta	1.21
Beta1y	0.38
Beta2y	-0.22
Ch YTD	-50
High	0.02
High52	0.04
High52 Date	2026-02-06
High52ch	-75%
Low	0.01
Low52	0.01
Low52 Date	2026-04-17
Low52ch	0%
Ma50ch	-49.49%
Price vs 200-day SMA	-58.51%
RSI	41.42
RSI Monthly	42.76
RSI Weekly	41.41
Sharpe ratio	1.43x
Sortino ratio	2.65
Tr YTD	-50
Tr1m	-60%
Tr3m	-66.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -349,342
Operating margin	-25.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,551,500%
Net Borrowing	376,706
Shares Insiders	74.9%
Shares Out	54,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	16,588.85x
Bv Per Share	-0.05
Ch1m	-60
Ch3m	-66.67
Ch3y	-80
Ch5y	-92.86
Ch6m	-60
Change	0%
Change From Open	-33.33
Close	0.01
Days Gap	50
Depreciation Amortization	83,305
Dollar Volume	200
Earnings Date	2026-05-12
EBIT	CAD -349,342
EBITDA	CAD -266,037
EPS	CAD -0.01
F Score	0
Financing CF	376,706
Fiscal Year End	December
Founded	2,014
Goodwill	212,949
Income Tax	CAD 1,631
Investing CF	45,397
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2025-12-31
Ma150	0.02
Ma150ch	-48.19%
Ma20	0.02
Ma20ch	-48.19%
Net CF	-190,979
Next Earnings Date	2026-05-12
Open	0.02
Position In Range	0
Ppne	222,768
Price Date	2026-04-17
Relative Volume	1.21x
Revenue	1,349,599x
Tax By Revenue	0.12x
Tr6m	-60%
Volume	20,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/WAVE pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/WAVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/WAVE?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+74.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TSXV/WAVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.4

Neutral momentum band

Price vs 200-day MA

-58.5%

50/200-day relationship not available

Beta (5Y)

1.21

More volatile than the market

Sharpe ratio

1.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/WAVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/WAVE stock rating?

tsxv/WAVE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/WAVE analysis?

The full report lives at /stocks/tsxv/WAVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/WAVE?

The latest report frames tsxv/WAVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/WAVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.